ORBIMED ADVISORS LLC Insider Trading Activity

Average Profitability
0.2%
Insider Buys Quantity
101
Insider Buys Sum
$604.98M
Insider Sells Quantity
220
Insider Sells Sum
$1.42B

Insider Activity of ORBIMED ADVISORS LLC

According to the SEC Form 4 filings, ORBIMED ADVISORS LLC, being in a position of

  1. 10 percent owner at Adicet Bio, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 104658 shares for $674,847,
    over all time since 2018-01-30, has bought 10066666 shares for $30.33M, and sold 104658 shares for $674,847.

Biography of ORBIMED ADVISORS LLC

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$28,498,206311
Sells
$108,032,5172489

Comparison of Insiders on Amount of Buys and Sells

2026-07-07SaleSionna Therapeutics, Inc.
SION
director
85,918
0.19%
$44.86$3.85M-86.55%
2026-06-30SaleSionna Therapeutics, Inc.
SION
director
115,844
0.2654%
$45.50$5.27M-85.88%
2026-06-22SaleEnliven Therapeutics, Inc.
ELVN
10 percent owner
860,123
1.2155%
$45.36$39.01M+10.74%
2026-06-15SaleEnliven Therapeutics, Inc.
ELVN
10 percent owner
281,408
0.4911%
$45.02$12.67M+20.05%
2026-05-28PurchaseQ32 Bio Inc.
QTTB
1.88M
11.3875%
$8.00$15M+22.6%
2026-05-27SaleSionna Therapeutics, Inc.
SION
director
101
0.0002%
$44.49$4,493-83.19%
2026-05-11SaleSionna Therapeutics, Inc.
SION
director
184,639
0.4127%
$46.22$8.53M-54.55%
2026-05-08SaleSionna Therapeutics, Inc.
SION
director
59,767
0.1339%
$44.58$2.66M-24.24%
2026-05-07SaleSionna Therapeutics, Inc.
SION
director
48,546
0.1111%
$44.61$2.17M-22.42%
2026-04-21PurchasePrelude Therapeutics Incorporated
PRLD
2.82M
4.8551%
$4.44$12.5M-4.87%
2026-04-18SaleSionna Therapeutics, Inc.
SION
director
2,948
0.0067%
$44.52$131,245-14.95%
2026-04-17SaleSionna Therapeutics, Inc.
SION
director
52,397
0.1195%
$44.68$2.34M-16.71%
2026-04-16SaleSionna Therapeutics, Inc.
SION
director
226,906
0.5071%
$45.34$10.29M-19.36%
2026-04-16PurchaseTraws Pharma, Inc.
TRAW
10 percent owner
597,729
10.3238%
$1.67$998,207-51.07%
2026-04-15SaleSionna Therapeutics, Inc.
SION
director
235,863
0.5189%
$44.64$10.53M-18.85%
2026-04-14SaleSionna Therapeutics, Inc.
SION
director
47,814
0.1216%
$44.51$2.13M-15.24%
2026-04-08SaleAdicet Bio, Inc.
ACET
10 percent owner
72,939
0.7583%
$6.42$468,082+25.19%
2026-04-07SaleAdicet Bio, Inc.
ACET
10 percent owner
31,719
0.335%
$6.52$206,765+27.53%
2026-02-03SaleSionna Therapeutics, Inc.
SION
director
29,063
0.0653%
$44.58$1.3M-16.93%
2026-02-02SaleSionna Therapeutics, Inc.
SION
director
1,890
0.0043%
$44.57$84,237-15.2%
Total: 289
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.